We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Where to get help if you are having suicidal thoughts, and what to do if you are worried about someone else.
What Works to Prevent Violence against Women and Girls: funding opportunity. Aims to build knowledge on what works to prevent violence against women and girls (VAWG).
How to use a crossover randomised controlled trial to evaluate your digital health product.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
Guidance for those affected by changes to UK immigration and borders due to coronavirus.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
How investigators and sponsors should manage clinical trials during COVID-19
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Guidance and support on coronavirus (COVID-19) in Scotland.
FCDO travel advice for British Indian Ocean Territory. Includes safety and security, insurance, entry requirements and legal differences.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Information from the National Health Service on conditions, treatments, local services and healthy living
Guidance for industry and organisations to follow from 1 January 2021.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information and guidance on a range of medical devices for users and patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.